Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types (Review)

Haibo Zhang, Song Park, Hai Huang, Eungyung Kim, Junkoo Yi, Seong Kyoon Choi, Zaeyoung Ryoo, Myoungok Kim

Research output: Contribution to journalReview articlepeer-review

33 Scopus citations

Abstract

Ginsenoside Rh2 (G-Rh2) is a natural bioactive product derived from Panax ginseng Meyer (P. ginseng). G-Rh2 exhibits anticancer activity in various human cancer cell lines both in vitro and in vivo by modulating several signaling pathways, such as those of PDZ-binding kinase/T-LAK cell-originated protein kinase, phosphatidylinositol 3-kinase, protein kinase B, mammalian target of rapamycin, epidermal growth factor receptor, p53, and reactive oxygen species. Moreover, G-Rh2 could effectively reverse drug resistance and enhance therapeutic effects in cancer therapy. This review summarizes the chemical properties, in vitro and in vivo anticancer activity, and underlying molecular mechanisms of G-Rh2 to facilitate cancer chemoprevention studies.

Original languageEnglish
Article number33
JournalOncology Reports
Volume45
Issue number4
DOIs
StatePublished - Apr 2021

Bibliographical note

Publisher Copyright:
© 2021 Spandidos Publications. All rights reserved.

Keywords

  • Anticancer
  • Ginsenoside Rh2
  • Mechanisms
  • Panax ginseng
  • Review

Fingerprint

Dive into the research topics of 'Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types (Review)'. Together they form a unique fingerprint.

Cite this